Anneke Spoorenberg

4.3k total citations
103 papers, 3.1k citations indexed

About

Anneke Spoorenberg is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Anneke Spoorenberg has authored 103 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Rheumatology, 41 papers in Immunology and 23 papers in Hematology. Recurrent topics in Anneke Spoorenberg's work include Spondyloarthritis Studies and Treatments (89 papers), Rheumatoid Arthritis Research and Therapies (46 papers) and Psoriasis: Treatment and Pathogenesis (40 papers). Anneke Spoorenberg is often cited by papers focused on Spondyloarthritis Studies and Treatments (89 papers), Rheumatoid Arthritis Research and Therapies (46 papers) and Psoriasis: Treatment and Pathogenesis (40 papers). Anneke Spoorenberg collaborates with scholars based in Netherlands, United States and France. Anneke Spoorenberg's co-authors include Désirée van der Heijde, Suzanne Arends, Herman Mielants, Elisabeth Brouwer, Hille van der Tempel, E. van der Veer, Maxime Dougados, Robert Landewé, Sjef van der Linden and Hendrika Bootsma and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Anneke Spoorenberg

96 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anneke Spoorenberg Netherlands 27 2.7k 1.3k 839 490 312 103 3.1k
Uta Kiltz Germany 24 2.0k 0.8× 1.3k 0.9× 742 0.9× 186 0.4× 207 0.7× 252 2.4k
R. Landewé Netherlands 21 2.7k 1.0× 1.9k 1.5× 1.1k 1.3× 234 0.5× 348 1.1× 50 3.5k
Victoria Navarro‐Compán Spain 25 2.0k 0.8× 1.1k 0.8× 693 0.8× 258 0.5× 139 0.4× 198 2.5k
Sylvester Garrett United Kingdom 9 3.6k 1.3× 1.7k 1.3× 1.2k 1.4× 379 0.8× 422 1.4× 10 3.9k
Ennio Lubrano Italy 32 2.5k 0.9× 1.9k 1.4× 1.1k 1.3× 113 0.2× 196 0.6× 196 3.2k
H Whitelock United Kingdom 5 4.7k 1.7× 2.2k 1.7× 1.5k 1.8× 492 1.0× 489 1.6× 5 5.0k
T Jenkinson United Kingdom 8 4.7k 1.7× 2.2k 1.7× 1.6k 1.8× 506 1.0× 483 1.5× 10 5.1k
A Cãlin United Kingdom 16 4.7k 1.8× 2.3k 1.7× 1.6k 1.9× 444 0.9× 454 1.5× 26 5.2k
Johanna Callhoff Germany 22 1.4k 0.5× 687 0.5× 518 0.6× 126 0.3× 88 0.3× 92 1.8k
Euthalia Roussou United Kingdom 14 1.6k 0.6× 878 0.7× 649 0.8× 120 0.2× 78 0.3× 32 1.8k

Countries citing papers authored by Anneke Spoorenberg

Since Specialization
Citations

This map shows the geographic impact of Anneke Spoorenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anneke Spoorenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anneke Spoorenberg more than expected).

Fields of papers citing papers by Anneke Spoorenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anneke Spoorenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anneke Spoorenberg. The network helps show where Anneke Spoorenberg may publish in the future.

Co-authorship network of co-authors of Anneke Spoorenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Anneke Spoorenberg. A scholar is included among the top collaborators of Anneke Spoorenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anneke Spoorenberg. Anneke Spoorenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Paap, Davy, Hans Timmerman, F. Wink, et al.. (2024). Value of the central sensitisation inventory in patients with axial spondyloarthritis. RMD Open. 10(4). e004528–e004528. 1 indexed citations
5.
Gensler, Lianne S., Davy Paap, Karina de Leeuw, et al.. (2024). The mSQUASH is a feasible and valid measurement tool to uniformly assess daily physical activity in patients with rheumatic diseases. RMD Open. 10(4). e004696–e004696. 2 indexed citations
6.
Wink, F., F. Maas, Reinhard Bos, et al.. (2024). Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis. Seminars in Arthritis and Rheumatism. 68. 152523–152523. 1 indexed citations
7.
Horváth, Barbara, et al.. (2023). Psoriasis seems often underdiagnosed in patient with axial spondyloarthritis. Arthritis Research & Therapy. 25(1). 145–145.
8.
9.
Benavent, Diego, Dora Pascual‐Salcedo, Chamaida Plasencia‐Rodríguez, et al.. (2023). Translation and cross-cultural adaptation of the mSQUASH into Spanish. Reumatología Clínica. 19(8). 436–441. 2 indexed citations
10.
11.
Paap, Davy, F. Wink, Reinhard Bos, et al.. (2021). Central sensitization has major impact on quality of life in patients with axial spondyloarthritis. Seminars in Arthritis and Rheumatism. 52. 151933–151933. 27 indexed citations
12.
Spoorenberg, Anneke, et al.. (2021). B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis. International Journal of Molecular Sciences. 22(24). 13325–13325. 26 indexed citations
13.
Passos, Valéria Lima, Annelies Boonen, Suzanne Arends, et al.. (2018). Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life. RMD Open. 4(2). e000755–e000755. 13 indexed citations
14.
Webers, Casper, Mart van de Laar, Jolanda J. Luime, et al.. (2018). Employment and the role of personal factors among patients with ankylosing spondylitis: a Dutch cross-sectional case-control study. RMD Open. 4(1). e000680–e000680. 15 indexed citations
15.
Maas, F., Suzanne Arends, F. Wink, et al.. (2017). Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitors. PLoS ONE. 12(6). e0177231–e0177231. 30 indexed citations
16.
Plasqui, Guy, Diane Lacaille, Suzanne Arends, et al.. (2016). Social Role Participation Questionnaire for patients with ankylosing spondylitis: translation into Dutch, reliability and construct validity. RMD Open. 2(1). e000177–e000177. 8 indexed citations
17.
Balink, Hans, Anneke Spoorenberg, P. M. Houtman, Arnd Brandenburg, & Hein J. Verberne. (2013). Early recognition of aortitis of the aorta ascendens with 18F-FDG PET/CT: syphilitic?. Clinical Rheumatology. 32(5). 705–709. 13 indexed citations
18.
Arends, Suzanne, Y.P.T. Kamsma, E. van der Veer, et al.. (2011). The Relation Between Daily Physical Activity Measured with the Accelerometer and Clinical Assessments in Patients with Ankylosing Spondylitis. Data Archiving and Networked Services (DANS). 2 indexed citations
19.
Arends, Suzanne, E. van der Veer, Henk Groen, et al.. (2011). Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in Ankylosing Spondylitis. The Journal of Rheumatology. 38(8). 1644–1650. 38 indexed citations
20.
Spoorenberg, Anneke, Astrid van Tubergen, Robert Landewé, et al.. (2005). Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Lara D. Veeken. 44(6). 789–795. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026